Race and ethnicity moderate the associations between lifetime psilocybin use and past year hypertension
Grant M. Jones, Jocelyn A. Ricard, Matthew K. Nock
Frontiers in Psychiatry June 24, 2024 DOI: 10.3389/fpsyt.2024.1169686 via OpenAlex
Summary
AI-generated from the abstractHypertension disproportionately affects racial and ethnic minorities. Using National Survey on Drug Use and Health data (2005–2014), the authors examined whether race and ethnicity modify the association between psilocybin use and past-year hypertension. Hispanic identity moderated this association. Non-Hispanic White individuals who used psilocybin had 17% lower odds of hypertension (adjusted odds ratio: 0.83), but no such protective association appeared for other racial or ethnic groups. The results indicate that the relationship between psychedelics and hypertension may differ by race and ethnicity, warranting further longitudinal and clinical research.
Study at a glance
| Characteristics | Observational cross-sectional analysis Longitudinal Peer reviewed |
|---|---|
| Population | Respondents to the National Survey on Drug Use and Health (2005–2014) |
| Intervention | Psilocybin |
| Topics | Psilocybin |
| Keywords | Nsduh Race Drug epidemiology Psilocybin research Racial health disparities |
| Citations | 5 |
| Key finding | Psilocybin use was associated with reduced odds of past-year hypertension only among Non-Hispanic White individuals, not among other racial or ethnic groups. |
Abstract
Background Hypertension is a major source of morbidity and mortality worldwide, particularly for racial and ethnic minorities who face higher rates of hypertension and worse health-related outcomes. Recent research has reported on protective associations between classic psychedelics and hypertension; however, there is a need to explore how race and ethnicity may moderate such associations. Methods We used data from the National Survey on Drug Use and Health (2005–2014) to assess whether race and ethnicity moderate the associations between classic psychedelic use – specifically psilocybin – and past year hypertension. Results Hispanic identity moderated the associations between psilocybin use and past year hypertension. Furthermore, individuals who used psilocybin and identified as Non-Hispanic White had reduced odds of hypertension (aOR: 0.83); however, these associations were not observed for any other racial or ethnic groups in our study for individuals who used psilocybin. Conclusion Overall, our results demonstrate that the associations between psychedelics and hypertension may vary by race and ethnicity. Longitudinal studies and clinical trials can further advance this research and determine whether such differences exist in causal contexts. Project registration https://osf.io/xsz2p/?view_only=0bf7b56749034c18abb2a3f8d3d4bc0b .